STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITALY
Clinical trial NCT05286138 · RECRUITING
Trial details
- NCT number
- NCT05286138
- Sponsor
- Società Italiana Talassemie ed Emoglobinopatie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-01
- Primary completion
- 2024-02-28
- Enrollment
- 10000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.